Des lésions précancéreuses au cancer invasif / From precancerous lesions to invasive carcinoma

C. Mascaux (Strasbourg, France)

Source: Virtual Congress 2020 – French programme 2020: Part I

Session: French programme 2020: Part I
Session type: Language session
Number: 4555

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Mascaux (Strasbourg, France). Des lésions précancéreuses au cancer invasif / From precancerous lesions to invasive carcinoma. Virtual Congress 2020 – French programme 2020: Part I

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Microbiote et cancer bronchique: l'exemple de l'immunothérapie / Microbiota and lung cancer: an example of immunotherapy Source: Virtual Congress 2021 – French programme 2021 Year: 2021
Où en sommes-nous dans le dépistage du cancer bronchique? Screening for lung cancer: where are we? Source: International Congress 2019 – French programme 2019: Part I Year: 2019
Innovations thérapeutiques dans le mésothéliomeTherapeutic innovation in mesothelioma Source: International Congress 2017 – French Programme 2017 Year: 2017
Diagnostic de l’EP chez la femme enceinte / Diagnosis of pulmonary embolism in pregnant women Source: Virtual Congress 2020 – French programme 2020: Part II Year: 2020
Place des anti-IL5 dans les pathologies éosinophiliques (hors asthme sévère) / Anti-IL-5 therapy for indications other than severe asthma Source: Virtual Congress 2020 – French programme 2020: Part II Year: 2020
Troubles respiratoires du sommeil et cancer : données épidémiologiques / Respiratory disorders associated with sleep and cancer: epidemiological data Source: Virtual Congress 2020 – French programme 2020: Part I Year: 2020
Exacerbation aiguë de la fibrose pulmonaire idiopathique: ce qu'il ne faut plus faire et ce qu'il reste à faire. / Acute exacerbation of idiopathic pulmonary fibrosis: what should not be done and what remains to be done? Source: Virtual Congress 2021 – French programme 2021 Year: 2021
Mucoviscidose: enfin des traitements ciblés / Cystic fibrosis: targeted therapies, at last ! Source: Virtual Congress 2020 – French programme 2020: Part I Year: 2020
Réduction volumique par spirales dans le traitement de l’emphysème sévèreLung reduction coil treatment in severe emphysema Source: International Congress 2016 – ERS/French Programme I Year: 2016
Exploration de la fonction respiratoire selon l'âge / Lung function testing and age Source: Virtual Congress 2020 – French programme 2020: Part II Year: 2020
The use of PET-CT calculated mass sud max/lymphadenopathy sud max ratios in the detection of mediastinal metastasis in lung cancer patients Source: Annual Congress 2010 - Vascular and solitary lesions Year: 2010
Prise en charge de l’aspergillose pulmonaire chronique Chronic pulmonary aspergillosis care Source: International Congress 2017 – French Programme 2017 Year: 2017
La thermoplastie dans l’asthme : corrélation clinique et histopathologiqueAsthma thermoplasty: clinical and histopathological correlation Source: International Congress 2017 – French Programme 2017 Year: 2017
Coaching et prise de décision partagée dans les maladies respiratoires chroniques Coaching and shared decision-making in chronic respiratory diseases Source: International Congress 2019 – French programme 2019: Part II Year: 2019
Où en est-on dans la prise en charge de la Covid en septembre 2021 ? / Management of COVID-19: where are we ? Source: Virtual Congress 2021 – French programme 2021 Year: 2021